Home/Neuraxpharm/Philipp Pohoralek
PP

Philipp Pohoralek

Country Manager Germany & Netherlands

Neuraxpharm

Neuraxpharm Pipeline

DrugIndicationPhase
Leriglitazon for X-ALDX-linked Adrenoleukodystrophy (X-ALD)Partnered Commercialization
Wearable Device for EpilepsyEpilepsy Monitoring/TreatmentCommercial Launch
Sanofi Established Products PortfolioVarious CNS DisordersCommercial Acquisition
Medical Cannabis ProgramVarious Qualifying ConditionsPilot Commercial